TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

TerrAscend Corp.TSX: TSND.TO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 308.53M shares rose 5.3% year over year, ahead of the +4.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.0% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +5.3% holds above the trailing-twelve-month pace of +4.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
308.53M-0.0% QoQ
Last fiscal yearDec 2025
301.08M+3.3% YoY
LTMMar 2026
305.61M+4.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.3%——
1 year+3.3%——
3-year CAGR+7.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
301.08M USD
Year-over-year change
+3.3%
4-year CAGR
+9.6%

Weighted Avg Shares (Diluted) vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • TSND.TO's LTM Mar 2026 weighted avg shares (diluted) of 305.61M shares is the 2nd highest of the 10 companies compared; the peer median is 45.37M shares.
  • Its year-over-year change of +4.7% is the 6th highest of 10, against a peer median of +11.5%.
  • Over three fiscal years its annual growth of +7.2% compares with a peer median of +5.6%.
TSND.TO Competitors Peer median
Weighted Avg Shares (Diluted) for TSND.TO and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 20261.58B +16.6%+21.3%
TSND.TOTerrAscend Corp.LTM Mar 2026305.61M +4.7%+7.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026134.1M +15.6%—
ACB.TOAurora Cannabis Inc.LTM Mar 202656.7M +3.3%+20.7%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 202645.37M +27.3%+27.5%
HLS.TOHLS Therapeutics Inc.LTM Mar 202631.4M -1.3%-0.9%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202630.57M +11.5%+2.8%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202626.09M +3.3%+0.5%
DR.TOMedical Facilities CorporationLTM Mar 202620.34M -14.4%-12.8%
Peer median (excluding TSND.TO) 45.37M+11.5%+5.6%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue243.36M240.45M317.33M306.68M265.12M
Cost of Revenue109.32M203.35M112.49M156.72M131.93M
Gross Profit134.04M119.74M138.02M149.96M133.19M
Gross Margin55.1%49.8%43.5%48.9%50.2%
Research & Development00000
Selling, General & Admin73.71M116.64M112.17M111.33M82.41M
Operating Expenses94.12M150.69M179.56M167.07M87.78M
Depreciation & Amortization13.63M24.6M22.7M22.99M17.51M
EBITDA44.96M(246.52M)(1.03M)6.16M62.92M
EBITDA Margin18.5%-102.5%-0.3%2.0%23.7%
Operating Income31.33M(23.04M)(19.87M)(17.11M)45.41M
Operating Margin12.9%-9.6%-6.3%-5.6%17.1%
Interest Income00000
Interest Expense24.57M37.9M35.11M35.4M36.93M
Other Income / Expenses12.46M(277.92M)(38.97M)(35.13M)(40.34M)
Income Before Tax43.78M(300.95M)(58.83M)(52.23M)5.06M
Pre-Tax Margin18.0%-125.2%-18.5%-17.0%1.9%
Income Tax Expense28.88M(10.46M)23.45M20.44M29.98M
Net Income3.06M(303.96M)(91.1M)(80.23M)(87.74M)
Net Margin1.3%-126.4%-28.7%-26.2%-33.1%
EPS (Basic)0.07(1.31)(0.32)(0.28)(0.29)
EPS (Diluted)0.01(1.31)(0.32)(0.28)(0.29)
Weighted Avg Shares181.06M244.35M279.29M291.51M301.08M
Weighted Avg Shares (Diluted)208.71M244.35M279.29M291.51M301.08M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.